Analysis and Quantification of Oxidized Low-Density Lipoprotein-Induced Lipid Droplets in Macrophages Through High-Content Screening: Application for Antiatherogenic Drugs Discovery-Reference-Cited by-同舟云学术

Analysis and Quantification of Oxidized Low-Density Lipoprotein-Induced Lipid Droplets in Macrophages Through High-Content Screening: Application for Antiatherogenic Drugs Discovery

Published:2019-07 Issue:5 Volume:17 Page:223-230
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Tsui Leo¹,Wang I-Jong²

Affiliation:

1. School of Pharmacy and Medical Technology, Putian University, Fujian, China.

2. Department of Ophthalmology, National Taiwan University Hospital, Taipei, Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2019.930

Reference20 articles.

1. The macrophage foam cell as a target for therapeutic intervention

2. Macrophage Differentiation to Foam Cells

3. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

4. Lipoproteins, macrophage function, and atherosclerosis: Beyond the foam cell?

5. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Ca²⁺-calpain signaling is a new mechanism using Laminaria japonica polysaccharide to prevent macrophage foam cell formation and atherosclerosis;Food & Function;2023

2. Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives;SLAS Discovery;2022-10

3. Cobalt Chloride Induces Macrophage Foam Cell Formation: A Chemical Hypoxia Model for Anti-Atherosclerotic Drug Screening;ASSAY and Drug Development Technologies;2021-01-01

4. MicroRNA‑217 is involved in the progression of atherosclerosis through regulating inflammatory responses by targeting sirtuin 1;Molecular Medicine Reports;2019-08-09